Cargando…
c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks
Prostate cancer (PCa) is the most common non-cutaneous cancer in men. The androgen receptor (AR), a ligand-activated transcription factor, constitutes the main drug target for advanced cases of the disease. However, a variety of other transcription factors and signaling networks have been shown to b...
Autores principales: | Barfeld, Stefan J., Urbanucci, Alfonso, Itkonen, Harri M., Fazli, Ladan, Hicks, Jessica L., Thiede, Bernd, Rennie, Paul S., Yegnasubramanian, Srinivasan, DeMarzo, Angelo M., Mills, Ian G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405195/ https://www.ncbi.nlm.nih.gov/pubmed/28412251 http://dx.doi.org/10.1016/j.ebiom.2017.04.006 |
Ejemplares similares
-
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
por: Barfeld, Stefan J., et al.
Publicado: (2015) -
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
por: Itkonen, Harri M, et al.
Publicado: (2019) -
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022) -
N-Linked Glycosylation Supports Cross-Talk between Receptor Tyrosine Kinases and Androgen Receptor
por: Itkonen, Harri M., et al.
Publicado: (2013) -
Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation
por: Yegnasubramanian, Srinivasan, et al.
Publicado: (2006)